-
My Account
My Account
BSE Live
Apr 16, 16:00Prev. Close
1703.05
Open Price
1705.00
Bid Price (Qty.)
1720.00 (11)
Offer Price (Qty.)
1726.00 (122)
NSE Live
Apr 16, 15:57Prev. Close
1709.60
Open Price
1710.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Yearly Results of Ajanta Pharma (in Rs. Cr.) | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 | |
| Net Sales/Income from operations | 2,196.42 | 1,772.62 | 1,830.45 | 1,753.68 | 1,529.26 | |
| Other Operating Income | -- | -- | -- | 69.03 | 22.50 | |
| Total Income From Operations | 2,196.42 | 1,772.62 | 1,830.45 | 1,822.71 | 1,551.76 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 556.22 | 388.71 | 375.43 | 373.31 | 397.21 | |
| Purchase of Traded Goods | 98.73 | 70.79 | 73.01 | 59.23 | 57.81 | |
| Increase/Decrease in Stocks | 9.02 | -67.38 | -49.15 | 7.29 | -41.02 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 437.82 | 389.37 | 342.89 | 269.78 | 235.38 | |
| Depreciation | 91.29 | 69.90 | 57.14 | 59.48 | 42.68 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 561.85 | 509.92 | 541.46 | 477.09 | 386.53 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 441.49 | 411.31 | 489.67 | 576.53 | 473.17 | |
| Other Income | 184.20 | 102.15 | 73.01 | 66.95 | 82.35 | |
| P/L Before Int., Excpt. Items & Tax | 625.69 | 513.46 | 562.68 | 643.48 | 555.52 | |
| Interest | 9.10 | 0.41 | 0.24 | 2.83 | 4.20 | |
| P/L Before Exceptional Items & Tax | 616.59 | 513.05 | 562.44 | 640.65 | 551.32 | |
| Exceptional Items | -3.92 | -- | -- | -- | -- | |
| P/L Before Tax | 612.67 | 513.05 | 562.44 | 640.65 | 551.32 | |
| Tax | 171.54 | 121.29 | 134.92 | 140.84 | 136.84 | |
| P/L After Tax from Ordinary Activities | 441.13 | 391.76 | 427.52 | 499.81 | 414.48 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 441.13 | 391.76 | 427.52 | 499.81 | 414.48 | |
| Equity Share Capital | 17.54 | 17.54 | 17.69 | 17.69 | 17.69 | |
| Reserves Excluding Revaluation Reserves | 2,443.29 | 2,123.44 | 1,913.81 | 1,486.25 | 1,107.10 | |
| Equity Dividend Rate (%) | 650.00 | 450.00 | -- | 650.00 | 400.00 | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 50.55 | 44.51 | 48.59 | 56.79 | 47.10 | |
| Diluted EPS | 50.55 | 44.51 | 48.58 | 56.78 | 47.10 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 50.55 | 44.51 | 48.59 | 56.79 | 47.10 | |
| Diluted EPS. | 50.55 | 44.51 | 48.58 | 56.78 | 47.10 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
12.02.2021
09.02.2021
03.02.2021
Ajanta Pharma share price jumps 7%, hits 52-week high as Q3 PAT zooms 64%
03.02.2021
Ajanta Pharma Standalone December 2020 Net Sales at Rs 733.16 crore, up 38.19% Y-o-Y
03.02.2021
Ajanta Pharma Standalone December 2020 Net Sales at Rs 733.16 crore, up 38.19% Y-o-Y
02.02.2021
02.02.2021
Ajanta Pharma Consolidated December 2020 Net Sales at Rs 748.74 crore, up 14.98% Y-o-Y
04.11.2020
Ajanta Pharma Consolidated September 2020 Net Sales at Rs 715.91 crore, up 11.38% Y-o-Y
